bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Free Report) shares fell 16.7% on Tuesday . The stock traded as low as $0.50 and last traded at $0.50. 25,600 shares changed hands during mid-day trading, an increase of 666% from the average session volume of 3,340 shares. The stock had previously closed at $0.60.
bioAffinity Technologies Stock Performance
The stock’s 50 day moving average price is $0.45 and its 200-day moving average price is $0.83.
bioAffinity Technologies Company Profile
bioAffinity Technologies, Inc, a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level.
Recommended Stories
- Five stocks we like better than bioAffinity Technologies
- 3 Dividend Kings To Consider
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- Best Aerospace Stocks Investing
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
Receive News & Ratings for bioAffinity Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioAffinity Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
